Lotus Eye Hospital and Institute LimitedQ1 FY27 Results & Financial Update
Lotus Eye Hospital and Institute Limited: Q1 FY27 standalone results and company financials – revenue ₹17.06 Cr, PAT ₹0.61 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Lotus Eye Hospital and Institute price & chart
Market price₹109.40
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Lotus Eye Hospital and Institute Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
During the quarter ended June 30, 2026 (Q1 FY27), Lotus Eye Hospital and Institute Limited reported standalone revenue from operations of INR 17.06 crore.
Total income for the period stood at INR 17.27 crore, which includes other income of INR 0.21 crore.
The company posted a profit before tax (PBT) of INR 1.01 crore for the quarter.
Profit after tax (PAT) for Q1 FY27 was recorded at INR 0.61 crore, translating to basic and diluted earnings per share (EPS) of INR 0.30.
Total expenses for the quarter were supported by notable overhead items, including finance costs of INR 0.51 crore and depreciation and amortization expenses of INR 1.64 crore.
Profit after tax was ₹0.61 Cr for the reported quarter. EPS was ₹0.30 for the reported quarter.
Lotus Eye Hospital and Institute Limited reported revenue from operations of INR 17.06 crore for the quarter ended June 30, 2026, alongside total income of INR 17.27 crore inclusive of other income of INR 0.21 crore.
01 · Business model
What does Lotus Eye Hospital and Institute do?
Lotus Eye Hospital and Institute Limited operates in the healthcare sector, providing specialized eye care services and medical education facilities.
The company generates its core revenue from ophthalmic treatments, surgeries, diagnostic procedures, and related clinical offerings on a standalone basis.
The primary revenue streams are generated through hospital healthcare operations, clinical services, medical procedures, and the sale of pharmaceutical products, surgical consumables, and optical items associated with eye care.
Geographically, the company operates across multiple locations in Tamil Nadu and Kerala, including Coimbatore, Salem, Tirupur, Mettupalayam, Kochi, Karur, and Gobichettipalayam, anchoring its service delivery model in regional hubs.
02 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹17.06 Cr |
| Total income | ₹17.27 Cr |
| Profit before tax | ₹1.01 Cr |
| Profit after tax | ₹0.61 Cr |
| EPS | ₹0.30 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 3.6% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 5.9% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹0.21 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
03 · Why it moved
Why the quarter looked the way it did
What drove revenue
Revenue from operations reached INR 17.06 crore for the quarter ended June 30, 2026, driven by patient footfalls, clinical procedures, and diagnostic services across regional centers.
Non-operating income contributed INR 0.21 crore to the total income of INR 17.27 crore during the quarter.
What drove margins
Staff costs of INR 3.65 crore formed the largest single cost component, reflecting clinical and administrative personnel overheads.
Cost of materials consumed was INR 2.63 crore, purchases of stock-in-trade stood at INR 2.54 crore, offset by a positive inventory change of INR 0.28 crore.
Service expenses accounted for INR 3.25 crore, while other expenses were maintained at INR 2.32 crore.
Depreciation and amortization charges of INR 1.64 crore and finance costs of INR 0.51 crore impacted bottom-line profitability during the quarter.
04 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
The company operates in a single reportable segment, specifically 'Eye Care related sales and services', under Ind AS 108 reporting standards.
05 · Reported developments
What changed operationally
The company returned to profitability with a net profit of INR 0.61 crore and PBT of INR 1.01 crore in Q1 FY27, compared to a net loss of INR 0.32 crore in the preceding quarter ended March 31, 2026.
06 · Items worth noticing
The line items that can distort a quick read
Exceptional items for the quarter included a net loss of INR 0.33 crore arising from the sale of property, plant, and equipment.
07 · Beyond the numbers
What changed beyond the numbers
Reported update
Board Approval
The standalone unaudited financial results for Q1 FY27 were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 10, 2026.
Reported update
Auditor Review
Statutory auditors Anbarasu & Jalapathi issued a limited review report on the standalone financial results for the quarter ended June 30, 2026.
08 · Previous-quarter changes
What changed since the previous quarter
Total expenses moderated from INR 14.56 crore in Q4 FY26 to INR 16.25 crore in Q1 FY27 alongside a revenue expansion from INR 13.61 crore to INR 17.06 crore.
09 · Key Q&A
The quarter, answered directly
What does Lotus Eye Hospital and Institute do?
Lotus Eye Hospital and Institute Limited operates in the healthcare sector, providing specialized eye care services and medical education facilities.
What is the clearest takeaway from Q1 FY27?
During the quarter ended June 30, 2026 (Q1 FY27), Lotus Eye Hospital and Institute Limited reported standalone revenue from operations of INR 17.06 crore.
What drove revenue or demand?
Revenue from operations reached INR 17.06 crore for the quarter ended June 30, 2026, driven by patient footfalls, clinical procedures, and diagnostic services across regional centers.
What mattered most for margins or profitability?
Staff costs of INR 3.65 crore formed the largest single cost component, reflecting clinical and administrative personnel overheads.
What changed operationally beyond the headline numbers?
The standalone unaudited financial results for Q1 FY27 were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 10, 2026.
What should the next disclosure help confirm?
Monitor the financial performance and patient volume trends in the upcoming Q2 FY27 reporting cycle.
10 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
11 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Subsequent Quarter Earnings: Monitor the financial performance and patient volume trends in the upcoming Q2 FY27 reporting cycle.
- 02
Cost Structure Stability: Track employee benefit expenses and material consumption patterns relative to top-line growth in future quarters.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.